All-phase Drug Development

TranScrip Partners have wide experience in drug development from early pre-clinical research through non-clinical drug development, translational medicine, clinical development, peri-registration activities to life cycle management. They have expertise in designing and implementing programmes from early development to registration and have been involved in a breadth of different therapeutic areas for both conventional chemicals and biologicals.

Partners have worked in head offices of large and small pharmaceutical companies and with collaborative teams of licensors and licensees. They can thus advise Clients on strategic and tactical issues, including portfolio/product reviews and positioning, due diligence reports, development of Target Product Profiles or competitor analyses. Co-operating with other pharmaceutical industry specialists, TranScrip can also provide expertise and support in related areas such as pharmaceutical manufacturing, audit, non-clinical studies and other aspects of drug development.

Many of the Partners have been involved in setting international regulatory and clinical guidelines, have lobbied for novel approaches to drug development and have changed precedent to allow valuable novel drugs to be registered. They can use their collective experience to ensure that both innovative and conventional trials are implemented as efficiently as possible, including feasibility studies, site selection, investigator meetings, trial management and medical monitoring.